Evaluating PSA Screening and New Diagnostic Methods for Prostate Cancer
Introduction
Recent medical reviews and trials have re-examined how effective Prostate-Specific Antigen (PSA) blood tests are at reducing deaths from prostate cancer. Additionally, researchers are exploring how analyzing tumor DNA can help create personalized treatment plans.
Main Body
A large Cochrane review of six trials involving about 800,000 people in North America and Europe suggests that PSA screening can reduce deaths from the disease. However, the benefit is small, preventing approximately two deaths for every 1,000 men screened. This update follows long-term data from a 23-year study in Europe, showing that screening is most useful for men who are expected to live for another ten to fifteen years. Despite these results, PSA testing is still debated because it often leads to overdiagnosis. This happens when doctors find slow-growing tumors that may never have caused problems, which then leads to unnecessary biopsies or surgeries. These procedures can cause serious side effects, such as urinary incontinence and erectile dysfunction. To solve this, experts suggest a more targeted approach using MRI scans and other biomarkers to decide who actually needs a biopsy. At the same time, researchers from University College London have studied circulating tumor DNA (ctDNA) in patients with advanced cancer. They found that combining ctDNA analysis with PSA levels can identify high-risk patients who have a much higher chance of death. This method could help doctors detect when a treatment is failing early, allowing them to change the therapy to better suit the individual patient.
Conclusion
Although PSA screening can reduce mortality, the actual benefit is limited. Therefore, doctors and patients should make a balanced, individual decision to avoid unnecessary treatments.
Learning
⚡ The 'Nuance Shift': Moving from Simple to Sophisticated
At the A2 level, you likely say things like: "This is a problem" or "This is a good thing." To reach B2, you need to express degree and balance. The provided medical text is a goldmine for this transition because it doesn't just say "screening works" or "screening is bad"—it uses Qualifiers.
🔍 The Discovery: Qualifiers and Contrast
Look at how the author balances two opposing ideas using specific "bridge words."
The A2 Way: "PSA tests save lives. But they cause problems." The B2 Way: "PSA screening can reduce deaths... However, the benefit is small."
Why this matters: In B2 English, you stop seeing things as black and white. You start using words that limit or expand a statement to be more precise.
🛠️ Tool Kit: Precision Vocabulary
Extract these from the text to upgrade your speaking/writing:
| A2 Word (Basic) | B2 Upgrade (From Text) | Why it's better |
|---|---|---|
| Bad / Hurt | Serious side effects | Specifies the type of negative impact. |
| Change | Personalized / Targeted | Shows that the change is intentional and specific. |
| Little | Limited | Sounds more academic and objective. |
| Also | Additionally | A formal signal that more information is coming. |
💡 The 'B2 Logic' Formula
To sound more fluent, try this structure found in the conclusion:
[Acknowledgment of Fact] [The Limitation] [The Solution]
Example from text: "Although PSA screening can reduce mortality [Fact], the actual benefit is limited [Limitation]. Therefore, doctors should make a balanced decision [Solution]."
Try it yourself: Next time you argue a point, don't just say "I agree." Say: "Although I agree with your point, the cost is too high; therefore, we need a cheaper option."